Skip to main content
. 2024 Jan 9;10:1180861. doi: 10.3389/fmed.2023.1180861

Table 1.

Impact of pharmacologic strategies on the occurrence of contrast-associated acute kidney injury.

Beneficial May be beneficial Inconsistent data No benefit May be harmful
Isotonic saline Prostaglandin E1
Trimetazidine
Nicorandil
Alprostadil
Alpha-tocopherol
Angiotensin converting enzyme inhibitor / angiotensin II receptor blockers
Calcium channel blockers
Theophylline
Ascorbic acid
Statins
N-acetylcysteine
Dopamine
Fenoldopam
Atrial natriuretic peptide
Mannitol
Furosemide